Board of Directors
Mr. Ulf Arne Wiinberg is an experienced CEO responsible for driving results in the pharma and OTC industry.
Serving Wyeth since 1981, Mr Wiinberg was a key personnel pushing for business model shifts and expansions which ultimately led to his position to provide strategic oversight as President of Wyeth Europe, Middle East, Africa and Canada. He then moved on as CEO of H. Lundbeck A/S where he rejuvenated pipelines and patents as well as expanded geographies to turnover a revenue of 13.5 billion DKK in 2014.
Currently Mr Wiinberg serves on the board of multiple drug development companies including Avillion LLP, Hansa Medical AB, UCB S.A., Alfa Laval AB, Agenus Inc and Nestle Health and Sciences. With more than 30 years of pharmaceutical experience, he also holds position as Board Member in the European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturer Association (IFPMA), Pharmaceutical Research and Manufacturers of America (PhRMA).